Oppenheimer & Co’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$744K Sell
61,239
-47
-0.1% -$643 0.01% 1010
2025
Q4
$861K Buy
61,286
+16,290
+36% +$231K 0.01% 863
2025
Q3
$642K Buy
44,996
+23,810
+112% +$356K 0.01% 1089
2025
Q2
$299K Buy
21,186
+7,580
+56% +$116K ﹤0.01% 1353
2025
Q1
$233K Buy
13,606
+29
+0.2% +$540 ﹤0.01% 1390
2024
Q4
$261K Buy
+13,577
New +$256K ﹤0.01% 1338
2021
Q1
Sell
-11,256
Closed -$164K 1443
2020
Q4
$164K Hold
11,256
﹤0.01% 1268
2020
Q3
$144K Hold
11,256
﹤0.01% 1202
2020
Q2
$142K Hold
11,256
﹤0.01% 1166
2020
Q1
$109K Buy
+11,256
New +$155K ﹤0.01% 1108

Other funds holding CCAP

Oppenheimer & Co's CCAP Position: Q1 2026 in Review

Oppenheimer & Co reduced its Crescent Capital BDC (CCAP) stake by 0.08% in Q1 2026, selling an estimated $643 and leaving 61,239 shares worth $744K. The position accounts for 0.01% of the portfolio, ranked #1010.

Oppenheimer & Co first reported a position in CCAP in Q1 2020 and has held it in 10 quarters since. The position peaked at $861K in Q4 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q1 2026.

  • Oppenheimer & Co held 61,239 shares of Crescent Capital BDC worth $744K as of Q1 2026.
  • Oppenheimer & Co sold 47 Crescent Capital BDC shares in Q1 2026, an estimated $643.
  • Crescent Capital BDC made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1010 holding.
  • Oppenheimer & Co first reported a position in Crescent Capital BDC in Q1 2020 and has held it in 10 quarters since.
  • Oppenheimer & Co's Crescent Capital BDC position peaked at $861K in Q4 2025.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.